The event is Europe's premier conference for pharmaceutical and biotechnology professionals exploring innovations in clinical supply chain management, bringing together over 500 attendees, 55 exhibitors and 30 speakers to discuss new technologies, regulatory updates and best practices for streamlining operations.
Visitors to Table 20 can explore MM Packaging's extensive range of clinical trial packaging solutions, including booklet labels, tamper-evident and cryogenic labels, clinical literature and blinding solutions. The company's presence at CTS Europe underlines its ongoing commitment to supporting pharmaceutical innovation through advanced packaging design and innovation.
MM Packaging experts, including Joe Monteiro, Key Account Manager, and Diarmuid Wilson, Managing Director at MM Glasnevin, will be available throughout the event to discuss how the company's portfolio of solutions can be tailored to specific clinical study requirements.
Joe commented: "In clinical trials, every detail matters - especially in labelling and packaging. We have the culture, processes, and security systems in place to ensure that every label and carton meets the highest standards of accuracy, compliance, and security. Our commitment to precision safeguards patient safety, maintains strict regulatory standards, and protects the integrity of investigational medicinal products (IMP)."
With more than three decades of experience in designing and manufacturing IMP labels, MM Packaging has developed robust quality systems that position it as a leading supplier to the clinical trial sector. All printed components are produced in pharmaceutical manufacturing facilities accredited to stringent PS 9000:2011 standards. The company is currently expanding its clinical trial capabilities at its Dublin plant, MM Packaging Glasnevin, demonstrating its proactive approach to meeting evolving market needs.
MM Packaging showcases clinical trial expertise at CTS Europe 2025
MM Packaging, secondary packaging specialist to the pharmaceutical sector, is set to demonstrate its comprehensive clinical trial solutions at Clinical Trial Supply (CTS) Europe 2025, taking place 25-26 February at the Hyatt Regency Barcelona Tower, Spain.
The event is Europe's premier conference for pharmaceutical and biotechnology professionals exploring innovations in clinical supply chain management, bringing together over 500 attendees, 55 exhibitors and 30 speakers to discuss new technologies, regulatory updates and best practices for streamlining operations.
Visitors to Table 20 can explore MM Packaging's extensive range of clinical trial packaging solutions, including booklet labels, tamper-evident and cryogenic labels, clinical literature and blinding solutions. The company's presence at CTS Europe underlines its ongoing commitment to supporting pharmaceutical innovation through advanced packaging design and innovation.
MM Packaging experts, including Joe Monteiro, Key Account Manager, and Diarmuid Wilson, Managing Director at MM Glasnevin, will be available throughout the event to discuss how the company's portfolio of solutions can be tailored to specific clinical study requirements.
Joe commented: "In clinical trials, every detail matters - especially in labelling and packaging. We have the culture, processes, and security systems in place to ensure that every label and carton meets the highest standards of accuracy, compliance, and security. Our commitment to precision safeguards patient safety, maintains strict regulatory standards, and protects the integrity of investigational medicinal products (IMP)."
With more than three decades of experience in designing and manufacturing IMP labels, MM Packaging has developed robust quality systems that position it as a leading supplier to the clinical trial sector. All printed components are produced in pharmaceutical manufacturing facilities accredited to stringent PS 9000:2011 standards. The company is currently expanding its clinical trial capabilities at its Dublin plant, MM Packaging Glasnevin, demonstrating its proactive approach to meeting evolving market needs.